Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/3/25 19:14 | 11/3/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | 13 | S.d | -1,243 | 18.20 | 0 | -68 | 54 | D | |||||||||||||||
10/30/25 18:02 | 10/30/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | 17 | S.d | -1,853 | 21.41 | 0 | -87 | 51 | D | |||||||||||||||
10/30/25 18:01 | 10/30/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | 6 | S.d | -370 | 16.59 | 0 | -22 | 77 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |